StocksFundsScreenerSectorsWatchlists
SIEN

SIEN - Sientra Inc Stock Price, Fair Value and News

0.07USD-0.01 (-12.50%)Market Closed

Market Summary

SIEN
USD0.07-0.01
Market Closed
-12.50%

SIEN Stock Price

View Fullscreen

SIEN RSI Chart

SIEN Valuation

Market Cap

837.0K

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.01

EV/EBITDA

0.33

Price/Free Cashflow

-0.07

SIEN Price/Sales (Trailing)

SIEN Profitability

EBT Margin

-65.68%

Return on Equity

-8.45%

Return on Assets

-42.25%

Free Cashflow Yield

-1.5K%

SIEN Fundamentals

SIEN Revenue

Revenue (TTM)

90.3M

Rev. Growth (Yr)

-13.41%

Rev. Growth (Qtr)

-15.5%

SIEN Earnings

Earnings (TTM)

-59.1M

Earnings Growth (Yr)

1.39%

Earnings Growth (Qtr)

-55.88%

Breaking Down SIEN Revenue

Last 7 days

-53.8%

Last 30 days

-14.3%

Last 90 days

-89.8%

Trailing 12 Months

-96.1%

How does SIEN drawdown profile look like?

SIEN Financial Health

Current Ratio

0.57

SIEN Investor Care

Shares Dilution (1Y)

18.40%

Diluted EPS (TTM)

-5.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202391.7M93.3M90.3M0
202283.8M85.2M88.1M90.5M
202165.6M76.4M80.7M80.7M
202083.1M71.9M64.8M64.2M
201971.0M74.0M79.5M83.7M
201843.7M53.1M60.2M68.1M
201726.8M28.7M32.0M36.5M
201627.1M19.2M15.8M20.7M
201546.9M49.4M48.7M38.1M
201436.9M39.2M41.9M44.7M
201316.6M22.8M29.0M35.2M
201200010.4M

Tracking the Latest Insider Buys and Sells of Sientra Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 13, 2023
van hove caroline f.
sold (taxes)
-526
0.71
-741
-
Nov 13, 2023
menezes ronald
sold (taxes)
-2,573
0.71
-3,625
president and ceo
Sep 07, 2023
bennett oliver christian
acquired
4,793
1.75
2,739
gc & chief compliance officer
Aug 03, 2023
schmidt andrew c
sold (taxes)
-2,165
3.86
-561
chief financial officer
Jun 15, 2023
schaison philippe
acquired
-
-
12,000
-
Jun 15, 2023
fisher mary
acquired
-
-
12,000
-
Jun 15, 2023
erenburg irina
acquired
-
-
12,000
-
Jun 15, 2023
ebersole nori
acquired
-
-
12,000
-
Jun 15, 2023
casdin alexander w.
acquired
-
-
15,000
-
Mar 22, 2023
schmidt andrew c
sold (taxes)
-3,750
1.38
-2,718
chief financial officer

1–10 of 50

Which funds bought or sold SIEN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 16, 2024
Williams & Novak, LLC
sold off
-100
-8,906
-
-%
Apr 15, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
sold off
-100
-16,836
-
-%
Apr 12, 2024
Dynamic Advisor Solutions LLC
sold off
-100
-10,330
-
-%
Mar 11, 2024
VANGUARD GROUP INC
reduced
-1.22
-717,668
198,598
-%
Feb 15, 2024
JANE STREET GROUP, LLC
sold off
-100
-70,751
-
-%
Feb 14, 2024
STATE STREET CORP
unchanged
-
-82,115
23,083
-%
Feb 14, 2024
WOLVERINE TRADING, LLC
sold off
-100
-29,115
-
-%
Feb 14, 2024
COMERICA BANK
sold off
-100
-834
-
-%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
new
-
82.00
82.00
-%
Feb 14, 2024
Creative Planning
unchanged
-
-59,061
16,602
-%

1–10 of 43

Are Funds Buying or Selling SIEN?

Are funds buying SIEN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SIEN
No. of Funds

Unveiling Sientra Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 20, 2024
rosalind advisors, inc.
0%
0
SC 13G/A
Feb 06, 2024
wells fargo & company/mn
8.8%
1,057,547
SC 13G
Feb 15, 2023
rosalind advisors, inc.
5.0%
509,274
SC 13G
Feb 10, 2023
senvest management, llc
0%
0
SC 13G/A
Dec 12, 2022
morgan stanley
0.4%
398,938
SC 13G/A
Nov 15, 2022
pessin norman h
5.6%
5,670,923
SC 13D
Jul 08, 2022
blackrock inc.
1.8%
1,125,864
SC 13G
May 04, 2022
clarus lifesciences i, l.p.
4.4%
2,730,765
SC 13D/A
Feb 11, 2022
senvest management, llc
5.3%
3,081,039
SC 13G
Feb 11, 2022
morgan stanley
5.9%
3,412,477
SC 13G

Recent SEC filings of Sientra Inc

View All Filings
Date Filed Form Type Document
Apr 18, 2024
8-K
Current Report
Apr 09, 2024
25-NSE
25-NSE
Mar 29, 2024
NT 10-K
NT 10-K
Feb 20, 2024
SC 13G/A
Major Ownership Report
Feb 16, 2024
8-K
Current Report
Feb 13, 2024
8-K
Current Report
Feb 06, 2024
SC 13G
Major Ownership Report
Jan 29, 2024
8-K
Current Report
Jan 16, 2024
8-K
Current Report

Peers (Alternatives to Sientra Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
186.2B
40.1B
-3.77% -2.76%
32.53
4.64
-8.12% -17.45%
67.7B
19.5B
-1.53% -10.57%
53.87
3.47
4.02% -22.04%
22.5B
3.9B
-9.16% -15.16%
50.45
5.81
3.42% 23.09%
20.0B
14.8B
-5.62% -8.72%
7.55
1.35
2.12% 209.17%
MID-CAP
9.2B
3.5B
-0.49% 17.01%
32.32
2.64
4.97% 18.89%
9.1B
12.3B
-5.22% -14.61%
21.9
0.74
-2.44% -22.68%
8.2B
2.7B
-16.90% -39.13%
-12.81
3.06
-4.68% 82.43%
6.3B
4.0B
-8.41% -25.34%
-47.02
1.6
1.10% 85.84%
3.4B
366.4M
-2.66% 12.41%
-562.39
9.32
33.86% 89.83%
2.3B
6.6B
-4.93% -3.92%
12.04
0.35
2.78% -0.87%
SMALL-CAP
1.2B
3.2B
-14.38% -20.49%
-1.83
0.39
7.73% -1066.14%
383.3M
166.7M
0.86% -5.21%
-4.64
2.3
6.67% -456.34%
250.3M
324.0M
11.81% -29.38%
-1.3
0.77
-3.19% -337.41%
45.7M
52.3M
-28.65% -55.25%
-2.44
0.87
17.61% 19.28%
3.8M
3.7M
-10.98% 147.46%
-0.31
1.02
5.77% 8.23%

Sientra Inc News

Latest updates
Yahoo Movies UK • 14 Apr 2024 • 01:10 pm
The Wall Street Journal • 2 months ago
Orange County Business Journal • 5 months ago

Sientra Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-15.5%19,544,00023,130,00022,557,00025,068,00022,570,00021,513,00021,398,00022,648,00019,620,00020,103,00018,312,00022,644,00015,329,0009,309,00016,932,00023,210,00022,412,00020,525,00017,552,00019,021,00016,875,000
Gross Profit-20.5%10,029,00012,615,00012,147,0003,231,00012,776,00012,742,00012,845,00012,327,00010,590,00011,265,00010,153,00011,075,0008,224,0005,262,00010,140,00014,239,00012,658,00012,712,00011,078,00011,354,00010,477,000
Operating Expenses-1.5%19,426,00019,726,00022,711,00027,690,00025,334,00028,680,00028,940,00026,054,00022,284,00020,422,00021,925,00017,825,00017,750,00014,500,00037,146,000-35,825,00034,118,00049,676,00036,929,00035,740,00030,039,000
  S&GA Expenses-6.7%9,330,00010,005,00010,152,00013,507,00012,290,00013,664,00015,588,00014,108,00012,052,00010,477,00011,819,0008,888,5009,969,0005,443,00016,763,000-23,063,00018,668,00021,918,00020,401,00021,726,50015,254,000
  R&D Expenses3.7%2,476,0002,387,0002,708,0004,240,0003,720,0002,959,0003,144,0003,494,0002,367,0002,400,0002,195,0002,233,5001,778,0002,113,0002,908,000581,5003,201,0003,270,0003,054,0003,013,5002,881,000
EBITDA Margin-2.3%-0.47-0.46-0.57-0.64-0.59-0.11-0.13-0.62-0.59-1.01-1.36-0.96-0.35--------
Interest Expenses-5.5%2,367,0002,506,0002,377,0002,528,0002,364,0002,323,0001,897,0002,111,0002,026,0002,113,0002,004,0002,154,0002,055,0003,606,0001,623,0001,290,0001,344,000982,000952,000953,500953,000
Income Taxes----27,000---21,000---33,000---34,000----4,000-
Earnings Before Taxes-55.9%-14,773,000-9,477,000-12,892,000-22,162,000-14,887,000-18,246,000-17,985,000-15,851,00028,503,000-18,539,000-56,611,000-13,017,000-1,487,000-31,208,000-28,612,00028,518,000-22,433,000-37,654,000-26,484,000-24,635,000-20,545,000
EBT Margin-3.2%-0.66-0.64-0.74-0.81-0.76-0.28-0.28-0.77-0.74-1.17-1.56-1.16-0.51--------
Net Income-55.9%-14,773,000-9,477,000-12,892,000-21,981,000-14,981,000-18,304,000-18,041,000-16,068,00028,410,000-20,134,000-54,690,000-21,237,000-5,821,000-34,277,000-28,612,000-20,247,000-22,433,000-37,654,000-26,484,000-24,631,000-20,545,000
Net Income Margin-3.0%-0.65-0.64-0.74-0.81-0.76-0.28-0.31-0.77-0.84-1.33-1.77-1.40-1.37--------
Free Cashflow-424.7%-3,636,000-693,000-6,886,000-2,951,000-3,742,000-13,611,000-18,161,000-11,871,000-16,162,000-4,284,000-13,988,000-8,243,000-7,137,000--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-4.2%140146153165166175192200187191198169178185223204220246172168181
  Current Assets-5.9%87.0092.0097.00108109118135141147152159129138145182157179204117136148
    Cash Equivalents-19.4%15.0019.0019.0026.0019.0025.0039.0052.0066.0082.0080.0055.0063.0072.0011288.0012114662.0087.00103
  Inventory-0.4%39.0039.0041.0043.0052.0053.0054.0053.0052.0045.0051.0039.0048.0046.0042.0040.0030.0030.0027.0024.0023.00
  Net PPE-5.0%13.0014.0015.0015.0014.0013.0013.0014.0015.0014.0013.0012.0013.0013.0012.0012.004.004.003.003.002.00
  Goodwill0%9.009.009.009.009.009.009.009.009.009.009.009.009.009.009.009.005.005.0013.0027.0013.00
Liabilities4.5%17216516416617016716715914622121117016016316812312413112910193.00
  Current Liabilities71.9%15288.0088.0090.0081.0084.0085.0080.0072.0072.0070.0071.0057.0051.0081.0070.0064.0088.0077.0064.0054.00
  Long Term Debt-100.0%-58.0057.0055.0070.0063.0066.0062.0061.0061.0061.0061.0063.0063.0056.0038.0038.0021.0024.0028.0031.00
    LT Debt, Current-59.00----9.005.002.00-7.006.005.001.00-25.007.007.0018.0013.007.003.00
    LT Debt, Non Current-100.0%-58.0057.0055.0070.0063.0066.0062.0061.0061.0061.0061.0063.0063.0056.0038.0038.0021.0024.0028.0031.00
Shareholder's Equity------9.0025.0041.0041.00---18.0022.0055.0082.0096.0011542.0067.0088.00
  Retained Earnings-2.1%-731-717-707-694-672-657-639-621-605-633-613-558-537-531-497-468-448-426-388-362-337
  Additional Paid-In Capital0.2%700699697694668666664662646602600558555554552551545541431429425
Shares Outstanding1.0%11.0011.0011.0011.006.006.006.006.006.006.005.005.005.00--------
Float------52.00---454---188,807---278,429---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-541.1%-3,366-525-6,268-1,216-2,699-13,044-17,915-12,948-14,450-2,435-12,667-7,399-6,140-19,410-27,189-13,530-24,873-23,984-24,646-14,772-10,261
  Share Based Compensation-7.8%1,2331,3381,7221,8201,8552,0622,1962,3172,3262,5843,1632,8791,5741,6352,1332,9143,0702,9113,7003,7474,391
Cashflow From Investing-60.7%-270-168-618-1,735-1,043-567-246-3,103-1,7129,465-1,321-844-997-989-1,206-18,834-1,124-1,446-610-441-254
Cashflow From Financing196.2%25.00-26.0017110,048-2,273-2825,2711,658-128-4,98539,393-283-1,179-19,86452,849-943824109,563312-896904

SIEN Income Statement

2023-09-30
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net sales$ 19,544,000$ 22,570,000$ 65,231,000$ 65,481,000
Cost of goods sold9,515,0009,794,00030,440,00027,118,000
Gross profit10,029,00012,776,00034,791,00038,363,000
Operating expenses:    
Sales and marketing9,330,00012,290,00029,487,00041,542,000
Research and development2,476,0003,720,0007,571,0009,823,000
General and administrative7,620,0009,324,00024,805,00031,589,000
Total operating expenses19,426,00025,334,00061,863,00082,954,000
Loss from operations(9,397,000)(12,558,000)(27,072,000)(44,591,000)
Other (expense) income, net:    
Interest income168,00041,000458,00058,000
Interest expense(2,367,000)(2,364,000)(7,250,000)(6,584,000)
Change in fair value of derivative liability(3,153,000)0(3,153,000)0
Other (expense) income, net(24,000)(6,000)(125,000)(1,000)
Total other (expense) income, net(5,376,000)(2,329,000)(10,070,000)(6,527,000)
Loss from continuing operations before income taxes(14,773,000)(14,887,000)(37,142,000)(51,118,000)
Income tax expense0000
Loss from continuing operations(14,773,000)(14,887,000)(37,142,000)(51,118,000)
Loss from discontinued operations, net of income taxes0(94,000)0(208,000)
Net loss$ (14,773,000)$ (14,981,000)$ (37,142,000)$ (51,326,000)
Basic net loss per common share    
Continuing operations$ (1.31)$ (2.37)$ (3.23)$ (8.16)
Discontinued operations0(0.01)0(0.03)
Basic net loss per share(1.31)(2.38)(3.23)(8.19)
Diluted net loss per common share    
Continuing operations(1.31)(2.37)(3.23)(8.16)
Discontinued operations0(0.01)0(0.03)
Diluted net loss per share$ (1.31)$ (2.38)$ (3.23)$ (8.19)
Weighted average outstanding common shares used for net loss per common share:    
Basic11,290,6996,284,81711,488,3106,261,350
Diluted11,290,6996,284,81711,488,3106,261,350

SIEN Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 15,026$ 26,071
Accounts receivable, net of allowances for doubtful accounts of $2,776 and $3,132 at September 30, 2023 and December 31, 2022, respectively29,61036,892
Inventories39,26842,692
Prepaid expenses and other current assets2,6042,094
Total current assets86,508107,749
Property and equipment, net13,28914,941
Goodwill9,2029,202
Other intangible assets, net24,33225,676
Right of use assets, net5,7537,004
Other assets849849
Total assets139,933165,421
Current liabilities:  
Current portion of long-term debt58,8100
Accounts payable5,2846,818
Accrued and other current liabilities20,65522,599
Customer deposits53,59845,161
Sales return liability13,74515,773
Total current liabilities152,09290,351
Long-term debt055,406
Derivative liability3,153880
Deferred and contingent consideration1,7942,791
Warranty reserve8,7588,186
Lease liabilities4,1295,518
Other liabilities2,0522,698
Total liabilities171,978165,830
Commitments and contingencies (Note 11)
Stockholders deficit:  
Preferred stock, $0.01 par value - Authorized 10,000,000 shares: none issued or outstanding00
Common stock, $0.01 par value - Authorized 200,000,000 shares; issued 11,375,478 and 10,709,716 and outstanding 11,368,205 and 10,702,444 shares at September 30, 2023 and December 31, 2022, respectively114107
Additional paid-in capital699,894694,395
Treasury stock, at cost (7,273 shares at September 30, 2023 and December 31, 2022)(260)(260)
Accumulated deficit(731,793)(694,651)
Total stockholders' deficit(32,045)(409)
Total liabilities and stockholders' deficit$ 139,933$ 165,421
SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California.
 CEO
 WEBSITEhttps://sientra.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES304

Sientra Inc Frequently Asked Questions


What is the ticker symbol for Sientra Inc? What does SIEN stand for in stocks?

SIEN is the stock ticker symbol of Sientra Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sientra Inc (SIEN)?

As of Thu Apr 18 2024, market cap of Sientra Inc is 837.04 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SIEN stock?

You can check SIEN's fair value in chart for subscribers.

What is the fair value of SIEN stock?

You can check SIEN's fair value in chart for subscribers. The fair value of Sientra Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Sientra Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SIEN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Sientra Inc a good stock to buy?

The fair value guage provides a quick view whether SIEN is over valued or under valued. Whether Sientra Inc is cheap or expensive depends on the assumptions which impact Sientra Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SIEN.

What is Sientra Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, SIEN's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SIEN PE ratio will change depending on the future growth rate expectations of investors.